Skip to Main Content
Important Announcement: The New Library System and updated E-resource login process are Here!. As part of
OhioLINK, Ohio's academic library consortium, the NEOMED Library is updating its 30-year-old shared systems. The new system allows researchers to "discover" print and electronic resources with a single search. Click
here to start using the new system.
Additionally, we have also changed the way that you all will login for off-campus access to the electronic resources provided by the NEOMED Library. All NEOMED students, faculty, clinical faculty, staff, and retirees, will click on the "Login using your NEOMED Network credentials" link on the login page. From there, you will be routed through NEOMED's network login process using the same login credentials that you use for logging into your email, Sharepoint, and other essential NEOMED networked resources.
Please be patient with us as we get everything situated for your use and contact us with any questions at 330-325-6600 or e-mail
library@neomed.edu for help.
Osteoarthritis
- Lumiracoxib versus celecoxib for treating osteoarthritis
- Celecoxib versus diclofenac for treating arthritis
- Celecoxib versus omeprazole and diclofenac for treating arthritis
- Glucosamine/chondroitin versus chondroitin for treating osteoarthritis
- Glucosamine/chondroitin versus glucosamine for treating osteoarthritis
- Glucosamine versus chondroitin for treating osteoarthritis
- Glucosamine/chondroitin versus celecoxib for treating osteoarthritis
- Meriva/glucosamine versus chondroitin/glucosamine for treating osteoarthritis
- Photo-activated platelet-rich plasma injections vs hyaluronic acid injections for treating osteoarthritis
- Chondroitin sulfate versus celecoxib for treating osteoarthritis
Gout & Hyperuricemia
- Febuxostat vs allopurinol for treating gout & hyperuricemia
- Cardiovascular safety of febuxostat vs allopurinol for the treatment of gout
Rheumatoid arthritis
- Comparing infliximab to adalimumab for treating rheumatoid arthritis
- Comparing infliximab to etanercept for treating rheumatoid arthritis
- Comparing methotrexate to rituximab for the treatment of rheumatoid arthritis
- Comparing methotrexate to rituximab with methotrexate for the treatment of rheumatoid arthritis
- Celecoxib vs. diclofenac for treating arthritis
- Tocilizumab vs. methotrexate for treating rheumatoid arthritis
- Celecoxib vs. omeprazole and diclofenac for treating arthritis
- Comparing etanercept with methotrexate to an etanercept monotherapy for treating rheumatoid arthritis
- Treating rheumatoid arthritis with disease-modifying antirheumatic drugs with or without ginger
Osteoporosis
- Alendronate vs. risedronate for treating osteoporosis
- Teriparatide and denosumab versus teriparatide alone for treating osteoporosis
- Teriparatide and denosumab versus denosumab alone for treating osteoporosis
- Ibandronate versus risedronate for treating osteoporosis
- Romosozumab versus alendronate for preventing fractures in women with osteoporosis
- Ibandronate versus alendronate for treating osteoporosis
Misc. Rheumatology Topics
- Prednisone versus cytotoxic drugs to treat lupus nephritis